anmelden
FTSE All-Share
5.576,38
PKT
-20,66
PKT
-0,37
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 10.02.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.02.26 | National Grid Buy | Jefferies & Company Inc. | |
| 09.02.26 | Shell (ex Royal Dutch Shell) Sector Perform | RBC Capital Markets | |
| 09.02.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 09.02.26 | Unilever Overweight | Barclays Capital | |
| 09.02.26 | Unilever Hold | Deutsche Bank AG | |
| 06.02.26 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 06.02.26 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 06.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 06.02.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 06.02.26 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 17.02.26 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 06.02.26 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 05.02.26 | Shell (ex Royal Dutch Shell) Kaufen | DZ BANK | |
| 05.02.26 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 05.02.26 | Vodafone Group Sell | UBS AG | |
| 05.02.26 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 05.02.26 | Shell (ex Royal Dutch Shell) Sector Perform | RBC Capital Markets | |
| 05.02.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.02.26 | Vodafone Group Underweight | JP Morgan Chase & Co. | |
| 05.02.26 | GSK Hold | Deutsche Bank AG | |
| 05.02.26 | Vodafone Group Buy | Deutsche Bank AG | |
| 05.02.26 | BAT Buy | Deutsche Bank AG | |
| 05.02.26 | HSBC Neutral | JP Morgan Chase & Co. | |
| 05.02.26 | BP Sector Perform | RBC Capital Markets | |
| 04.02.26 | London Stock Exchange (LSE) Buy | UBS AG | |
| 04.02.26 | GSK Buy | Jefferies & Company Inc. | |
| 02.02.26 | Shell (ex Royal Dutch Shell) Sector Perform | RBC Capital Markets | |
| 02.02.26 | London Stock Exchange (LSE) Overweight | Barclays Capital | |
| 30.01.26 | Diageo Outperform | RBC Capital Markets | |
| 29.01.26 | BAT Neutral | JP Morgan Chase & Co. | |
| 29.01.26 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 28.01.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.01.26 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 28.01.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.26 | Diageo Buy | Jefferies & Company Inc. | |
| 27.01.26 | GSK Hold | Deutsche Bank AG | |
| 27.01.26 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
| 27.01.26 | Diageo Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |